TWIST BIOSCIENCE CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.07 USD | -1.87% |
|
+23.64% | +24.99% |
| Sep. 12 | Twist Bioscience's Oregon Site Gets LEED Certification for Sustainable Operations | MT |
| Aug. 27 | Top Premarket Gainers | MT |
Chart calendar Twist Bioscience Corporation
3a73ee.JdL7v09GaJvZGJDqfIFPte3YAIpgGebn9lkjHYtTx9s.RpfJ-3sNWaPhTf2ECfQl466yVOgDQLOpxxhldsoYg6FclaHuKzMOw6h12Q~cf33336a7ddaf6e1a4911f704d17d32e
Upcoming events on Twist Bioscience Corporation
Past events on Twist Bioscience Corporation
| 2024-09-10 02:35 pm | Baird Global Healthcare Conference |
| 2024-08-02 08:00 am | Q3 2024 Earnings Call |
| 2024-08-02 07:30 am | Q3 2024 Earnings Release |
| 2024-06-11 10:00 am | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2024-06-06 08:30 am | Jefferies Global Healthcare Conference |
| 2024-06-04 03:40 pm | William Blair Growth Stock Conference |
| 2024-05-29 03:20 pm | Leerink Partners Healthcare Crossroads Conference - Fireside Chat |
| 2024-05-02 04:30 pm | Q2 2024 Earnings Call |
| 2024-05-02 04:05 pm | Q2 2024 Earnings Release |
| 2024-03-12 07:30 am | Barclays Global Healthcare Conference |
| 2024-03-05 11:10 am | TD Cowen Health Care Conference |
| 2024-02-07 06:00 pm | Advances in Genome Biology and Technology General Meeting - Emily M. Leproust |
| 2024-02-07 04:45 pm | Advances in Genome Biology and Technology General Meeting - Development of a high-throughput NGS lib |
| 2024-02-06 01:30 pm | Advances in Genome Biology and Technology General Meeting - Twist Pan-Cancer Reference Standards V2 |
| 2024-02-06 08:00 am | Annual General Meeting |
| 2024-02-02 08:00 am | Q1 2024 Earnings Call |
| 2024-02-02 07:30 am | Q1 2024 Earnings Release |
| 2024-01-08 08:15 pm | JPMorgan Healthcare Conference |
| 2023-11-28 07:30 am | Evercore ISI HealthCONx Conference |
| 2023-11-17 08:00 am | Q4 2023 Earnings Call |
Annual results
| Fiscal Period | September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 132 131 1.16% | 204 203 0.17% | 245 242 1.48% | 311 | 376 | 453 |
|
EBITDA Million USD | Released Forecast Spread | -144 -142 -1.17% | -218 -236 7.34% | -188 -195 3.69% | -172 | -119 | -16,8 |
|
EBIT Million USD | Released Forecast Spread | -153 -152 -1% | -235 -251 6.48% | -217 -215 -1.19% | -220 | -158 | -113 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -154 -152 -1.37% | -228 -251 9.1% | -203 -205 0.55% | -204 | -150 | -103 |
|
Net income Million USD | Released Forecast Spread | -152 -151 -0.94% | -218 -240 9.15% | -205 -207 1.15% | -205 | -149 | -102 |
|
EPS USD | Released Forecast Spread | -3,15 -3,15 0% | -4,04 -4,44 8.94% | -3,60 -3,77 4.48% | -3,45 | -2,47 | -1,88 |
| Announcement Date | 22/11/21 | 18/11/22 | 17/11/23 | - |
Quarterly results
| Fiscal Period | June | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 57,3 57,0 0.46% | 54,2 54,5 -0.42% | 60,2 56,6 6.34% | 63,7 60,7 5.03% | 66,9 63,5 5.51% | 71,5 67,6 5.78% | 75,3 70,8 6.42% | 81,5 77,4 5.29% | 82,6 | 85,7 | 91,1 | 96,8 | 97,4 |
|
EBITDA Million USD | Released Forecast Spread | -43,5 -55,2 21.24% | -52,3 -60,0 12.85% | -41,6 -43,6 4.56% | -38,8 -39,1 0.75% | -40,6 -39,4 -3.01% | -35,7 -35,0 -1.97% | -34,1 | ||||||
|
EBIT Million USD | Released Forecast Spread | -56,9 -71,0 19.92% | -48,8 -63,0 22.6% | -62,8 -65,1 3.54% | -60,8 -64,6 5.89% | -50,1 -51,7 3% | -47,0 -47,3 0.64% | -48,9 -49,6 1.37% | -44,0 -45,8 3.9% | -43,3 | -39,7 | -36,9 | -32,7 | -33,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,8 -74,4 31.66% | -41,7 -61,6 32.22% | -58,5 -64,2 8.97% | -56,8 -65,7 13.6% | -46,5 -52,5 11.46% | -42,9 -46,2 7.08% | -45,1 -48,4 6.66% | -85,4 -44,9 -90.01% | -42,2 | ||||
|
Net income Million USD | Released Forecast Spread | -51,1 -73,4 30.33% | -41,8 -60,9 31.33% | -59,2 -64,2 7.84% | -57,4 -65,1 11.84% | -46,2 -52,5 11.94% | -43,0 -46,6 7.76% | -45,5 -48,7 6.61% | -85,6 -45,3 -88.9% | -42,5 | -42,0 | -39,0 | -35,0 | -33,0 |
|
EPS USD | Released Forecast Spread | -0,91 -1,29 29.29% | -0,74 -1,10 32.75% | -1,04 -1,15 9.63% | -1,01 -1,14 11.6% | -0,81 -0,95 14.53% | -0,75 -0,78 3.61% | -0,79 -0,82 4.02% | -1,47 -0,77 -92.05% | -0,69 | -0,71 | -0,66 | -0,60 | -0,57 |
| Announcement Date | 18/11/22 | 03/02/23 | 05/05/23 | 04/08/23 | 17/11/23 | 02/02/24 | 02/05/24 | 02/08/24 | - | - | - | - | - |
More events
Past sector events for Twist Bioscience Corporation
| 2024-09-09 04:05 pm | AVID BIOSERVICES, INC.: Q1 2025 Earnings Release |
| 2024-09-05 06:30 am | KALVISTA PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2024-08-30 11:56 pm | SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-30 | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL VACCINE INC.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL ENGINEERING INC.: Q2 2024 Earnings Release |
| 2024-08-29 07:32 am | CLINUVEL PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | AIM VACCINE CO., LTD.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TWST Stock
- Calendar Twist Bioscience Corporation